Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
Shapiro
R
R
University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute, PA, USA.
Scantlebury
V P
VP
Jordan
M L
ML
Vivas
C
C
Gritsch
H A
HA
McCauley
J
J
Fung
J J
JJ
Hakala
T R
TR
Simmons
R L
RL
Starzl
T E
TE
D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016559:Tacrolimus